blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3056246

EP3056246 - SYSTEM FOR NON-ABLATIVE ACNE TREATMENT AND PREVENTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.09.2019
Database last updated on 17.05.2024
FormerThe patent has been granted
Status updated on  12.10.2018
FormerGrant of patent is intended
Status updated on  18.04.2018
FormerExamination is in progress
Status updated on  21.07.2017
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
Guided Therapy Systems, L.L.C.
33 South Sycamore Street
Mesa, Arizona 85202 / US
[2016/33]
Inventor(s)01 / MAKIN, Inder Raj S.
3052 North Diego Street
Mesa, AZ 85215 / US
02 / BARTHE, Peter G.
15002 South 30th Street
Phoenix, AZ 85048 / US
03 / SLAYTON, Michael H.
1323 East Whalers Way
Tempe, AZ 85283 / US
 [2016/33]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2018/46]Maiwald Patent- und Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Former [2016/33]Maiwald Patentanwalts GmbH
Elisenhof
Elisenstrasse 3
80335 München / DE
Application number, filing date16152592.818.09.2007
[2016/33]
Priority number, dateUS20060826039P18.09.2006         Original published format: US 826039 P
[2016/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3056246
Date:17.08.2016
Language:EN
[2016/33]
Type: B1 Patent specification 
No.:EP3056246
Date:14.11.2018
Language:EN
[2018/46]
Search report(s)(Supplementary) European search report - dispatched on:EP04.07.2016
ClassificationIPC:A61N7/00, A61M37/00
[2016/33]
CPC:
A61N7/02 (EP,US); A61P17/08 (EP); A61P17/10 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61B2017/00747 (EP,US);
A61B2017/22008 (EP,US); A61B2018/00666 (EP,US); A61B8/4272 (EP,US);
A61M37/0092 (EP,US); A61N2007/0008 (EP,US); A61N2007/0078 (EP,US);
A61N7/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/33]
TitleGerman:SYSTEM ZUR NICHTABLATIVEN AKNEBEHANDLUNG UND -VORBEUGUNG[2016/33]
English:SYSTEM FOR NON-ABLATIVE ACNE TREATMENT AND PREVENTION[2016/33]
French:SYSTÈME POUR LE TRAITEMENT NON ABLATIF DE L'ACNÉ ET SA PRÉVENTION[2016/33]
Examination procedure25.01.2016Examination requested  [2016/33]
16.02.2017Amendment by applicant (claims and/or description)
24.07.2017Despatch of a communication from the examining division (Time limit: M04)
30.11.2017Reply to a communication from the examining division
19.04.2018Communication of intention to grant the patent
16.08.2018Fee for grant paid
16.08.2018Fee for publishing/printing paid
16.08.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07853548.1  / EP2117650
EP11190853.9  / EP2428251
Divisional application(s)EP18206012.9   Application deemed to be withdrawn  : 14.12.2018
Opposition(s)15.08.2019No opposition filed within time limit [2019/43]
Fees paidRenewal fee
25.01.2016Renewal fee patent year 03
25.01.2016Renewal fee patent year 04
25.01.2016Renewal fee patent year 05
25.01.2016Renewal fee patent year 06
25.01.2016Renewal fee patent year 07
25.01.2016Renewal fee patent year 08
25.01.2016Renewal fee patent year 09
29.09.2016Renewal fee patent year 10
29.09.2017Renewal fee patent year 11
26.09.2018Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.09.2007
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
[2021/32]
Former [2021/26]AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2020/17]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
TR14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/50]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/40]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
SK14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/37]AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
RO14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/35]AT14.11.2018
CZ14.11.2018
DK14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
PL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/34]AT14.11.2018
DK14.11.2018
ES14.11.2018
FI14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/26]AT14.11.2018
ES14.11.2018
FI14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/24]AT14.11.2018
ES14.11.2018
FI14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
SE14.11.2018
BG14.02.2019
GR15.02.2019
IS14.03.2019
Former [2019/23]AT14.11.2018
ES14.11.2018
FI14.11.2018
LT14.11.2018
LV14.11.2018
NL14.11.2018
BG14.02.2019
IS14.03.2019
Former [2019/22]FI14.11.2018
LT14.11.2018
BG14.02.2019
IS14.03.2019
Former [2019/21]FI14.11.2018
LT14.11.2018
IS14.03.2019
Former [2019/20]LT14.11.2018
Documents cited:Search[XI]US4372296  (FAHIM MOSTAFA S [US]) [X] 1-3,5,7,8,11 * column 4, lines 42-55 * [I] 12;
 [X]US5267985  (SHIMADA JIN [US], et al) [X] 1-4,7,8,11-13* column 4, lines 6-21; figure 5A; claims 1,7 *;
 [X]WO9939763  (CHILDRENS MEDICAL CENTER [US]) [X] 1-3,5-9,11,13 * page 8, lines 10-25 *;
 [X]WO0021612  (ULTRA CURE LTD [IL], et al) [X] 1-11,13 * page 10, line 12 - page 12, line 5 * * page 22, lines 6-24 *;
 [X]US2002156400  (BABAEV EILAZ [US]) [X] 1-5,7-13 * paragraphs [0017] , [0055]; figure 2 *;
 [X]US6623430  (SLAYTON MICHAEL H [US], et al) [X] 1-5,7-13 * column 5, lines 42-60 * * column 14, lines 59-61; figures 2,4,6 *;
 [XI]US2004024348  (REDDING BRUCE K [US]) [X] 1-3,5,6,11 * paragraphs [0052] , [0061] , [0070] , [0074] , [0090] * [I] 12;
 [XI]US2004186384  (BABAEV EILAZ [US]) [X] 1-3,5-9 * paragraphs [0015] , [0019] , [0043] , [0053] , [0062] , [0077]; figure 3 * [I] 11,12;
 [X]US2006074355  (SLAYTON MICHAEL H [US], et al) [X] 1-9,11-13 * paragraphs [0017] - [0020]; claims 36-38 *;
 [X]WO2006042201  (GUIDED THERAPY SYSTEMS LLC [US], et al) [X] 1,6-11,13 * page 6, line 1 - page 7, line 29 * * page 24, lines 13-15 * * page 22, lines 17-27 *;
 [X]US2006094988  (TOSAYA CAROL A [US], et al) [X] 1-9,11-13 * paragraphs [0060] , [0077] , [0106] , [0114] , [0116] , [0124] - [0126]; figure 3b *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.